Evaluation of Magnesium-Phosphate Particle Incorporation into Co-Electrospun Chitosan-Elastin Membranes for Skin Wound Healing.
chitosan
elastin
electrospinning
tissue engineering
wound healing
Journal
Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729
Informations de publication
Date de publication:
29 Sep 2022
29 Sep 2022
Historique:
received:
25
08
2022
revised:
26
09
2022
accepted:
27
09
2022
entrez:
26
10
2022
pubmed:
27
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Major challenges facing clinicians treating burn wounds are the lack of integration of treatment to wound, inadequate mechanical properties of treatments, and high infection rates which ultimately lead to poor wound resolution. Electrospun chitosan membranes (ESCM) are gaining popularity for use in tissue engineering applications due to their drug loading ability, biocompatibility, biomimetic fibrous structure, and antimicrobial characteristics. This work aims to modify ESCMs for improved performance in burn wound applications by incorporating elastin and magnesium-phosphate particles (MgP) to improve mechanical and bioactive properties. The following ESCMs were made to evaluate the individual components' effects; (C: chitosan, CE: chitosan-elastin, CMg: chitosan-MgP, and CEMg: chitosan-elastin-MgP). Membrane properties analyzed were fiber size and structure, hydrophilic properties, elastin incorporation, MgP incorporation and in vitro release, mechanical properties, degradation profiles, and in vitro cytocompatibility with NIH3T3 fibroblasts. The addition of both elastin and MgP increased the average fiber diameter of CE (~400 nm), CMg (~360 nm), and CEMg (565 nm) compared to C (255 nm). Water contact angle analysis showed elastin incorporated membranes (CE and CEMg) had increased hydrophilicity (~50°) compared to the other groups (C and CMg, ~110°). The results from the degradation study showed mass retention of ~50% for C and CMg groups, compared to ~ 30% seen in CE and CEMg after 4 weeks in a lysozyme/PBS solution. CMg and CEMg exhibited burst-release behavior of ~6 µg/ml or 0.25 mM magnesium within 72 h. In vitro analysis with NIH3T3 fibroblasts showed CE and CEMg groups had superior cytocompatibility compared to C and CMg. This work has demonstrated the successful incorporation of elastin and MgP into ESCMs and allows for future studies on burn wound applications.
Identifiants
pubmed: 36286439
pii: md20100615
doi: 10.3390/md20100615
pmc: PMC9604583
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Chitosan
9012-76-4
Elastin
9007-58-3
Magnesium
I38ZP9992A
Muramidase
EC 3.2.1.17
Phosphates
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Czech Academy of Sciences
ID : UofM-20-01
Références
Nature. 2007 Feb 22;445(7130):874-80
pubmed: 17314974
Acta Biomater. 2022 Jun;145:172-184
pubmed: 35417797
Biomed Res Int. 2014;2014:624645
pubmed: 25405204
Front Biosci. 2005 May 01;10:1177-82
pubmed: 15769616
Biol Blood Marrow Transplant. 2010 Dec;16(12):1693-9
pubmed: 20541024
J Biomed Mater Res B Appl Biomater. 2012 Jul;100(5):1435-43
pubmed: 22287502
Mater Sci Eng C Mater Biol Appl. 2015 Jan;46:348-58
pubmed: 25491997
Biomaterials. 2007 Aug;28(24):3478-88
pubmed: 17482258
Adv Skin Wound Care. 2001 Jan-Feb;14(1):37-44; quiz 45-6
pubmed: 11905455
Clin Dermatol. 2005 Jul-Aug;23(4):403-12
pubmed: 16023936
Int J Biol Macromol. 2018 Dec;120(Pt A):385-393
pubmed: 30110603
Mar Drugs. 2021 Mar 22;19(3):
pubmed: 33809867
Medicina (Kaunas). 2021 Apr 15;57(4):
pubmed: 33920783
Prog Biomater. 2014 Feb 21;3(1):20
pubmed: 29470669
J Biomater. 2020 Dec;4(2):51-57
pubmed: 34056619
Molecules. 2021 Jul 01;26(13):
pubmed: 34279375
Clin Microbiol Rev. 2006 Apr;19(2):403-34
pubmed: 16614255
Int J Mol Sci. 2021 Oct 19;22(20):
pubmed: 34681930
Biomaterials. 2003 Dec;24(27):4977-85
pubmed: 14559011
Wound Repair Regen. 2009 Nov-Dec;17(6):763-71
pubmed: 19903300
Int J Mol Sci. 2017 Apr 07;18(4):
pubmed: 28387714
J Healthc Eng. 2018 Nov 13;2018:3651480
pubmed: 30538809
J Mater Sci Mater Med. 2012 Dec;23(12):2831-7
pubmed: 22890518
Afr J Emerg Med. 2017 Mar;7(1):30-37
pubmed: 30456103
Biomacromolecules. 2013 Jul 8;14(7):2403-10
pubmed: 23692358
Biomater Sci. 2018 Jul 24;6(8):2197-2208
pubmed: 30003209
Int J Biol Macromol. 2017 Oct;103:1311-1326
pubmed: 28583874
Polymers (Basel). 2019 May 06;11(5):
pubmed: 31064069
J R Soc Interface. 2007 Jun 22;4(14):413-37
pubmed: 17251138
J Periodontal Res. 2021 Oct;56(5):877-884
pubmed: 33830521
Mater Sci Eng C Mater Biol Appl. 2012 Oct 1;32(7):1711-1726
pubmed: 34062651
Int J Pharm. 2020 Jun 30;584:119438
pubmed: 32433935
Expert Rev Anti Infect Ther. 2011 Jul;9(7):857-79
pubmed: 21810057
J Am Acad Dermatol. 1994 Jul;31(1):49-53
pubmed: 8021371
Polymers (Basel). 2021 May 06;13(9):
pubmed: 34066640
Biomaterials. 2007 Oct;28(30):4378-98
pubmed: 17631957
Angiogenesis. 2001;4(1):21-8
pubmed: 11824374
Eplasty. 2009 Jun 26;9:e25
pubmed: 19633707
J Craniofac Surg. 2018 Oct;29(7):1788-1793
pubmed: 30157141
Int J Endocrinol. 2018 Apr 16;2018:9041694
pubmed: 29849626
Biomed Mater. 2016 Dec 02;12(1):015003
pubmed: 27910815
Talanta. 2006 Oct 15;70(3):561-5
pubmed: 18970808
J Biol Eng. 2017 Dec 13;11:49
pubmed: 29255480
Int J Biol Macromol. 2017 Dec;105(Pt 1):1241-1249
pubmed: 28757422